Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 27 sector : Health technology save search
TherapeuticsMD to Report Third Quarter 2021 Results on November 11, 2021
Published: 2021-10-27 (Crawled : 16:20) - ir.therapeuticsmd.com
TXMD | News | $1.88 -0.27% 15K
|
Health Technology
|
| O: -1.92%
H: 5.34%
C: 5.06%
results
russian wives – The Russian Effort To Abolish Marriage
Published: 2021-10-27 (Crawled : 04:00) - oncocyte.com
OCX | News | $2.3 -6.31% -6.74% 41K
|
Health Technology
|
| O: 2.17%
H: 4.24%
C: 3.03%
russia
RECONAFRICA DEADLINE: Reconnaissance Energy Africa Ltd. f/k/a Lund Enterprises Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RECAF; LGDOF
Published: 2021-10-27 (Crawled : 00:00) - prnewswire.com
BMRN | $91.25 -0.88% -0.89% 1.6M
|
Health Technology
|
| O: 2.48%
H: 6.83%
C: 6.39%
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 0.22%
H: 1.74%
C: 1.74%
energy africa
Repare Therapeutics Announces Proposed Public Offering of Common Shares
Published: 2021-10-27 (Crawled : 00:00) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: 0.7%
H: 0.84%
C: -1.07%
RPTX 4 | $3.3 -1.79% -1.82% 73K
|
Health Technology
|
| O: -0.39%
H: 4.04%
C: 2.13%
offering therapeutics publication
Appendix 4C & Activity Report
Published: 2021-10-27 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: -4.29%
H: 6.56%
C: 4.41%
report
Vanda Pharmaceuticals to Announce Third Quarter 2021 Financial Results on November 3, 2021
Published: 2021-10-27 (Crawled : 23:00) - biospace.com/
VNDA | $4.57 -1.3% -1.31% 1.5M
|
Health Technology
|
| O: -1.33%
H: 1.69%
C: 0.34%
financial results results
Precigen to Host R&D Update Virtual Event on November 4th to Share Clinical Developments
Published: 2021-10-27 (Crawled : 23:00) - biospace.com/
PGEN | $1.42 1.43% 1.41% 560K
|
Health Technology
|
| O: -0.43%
H: 1.31%
C: -1.75%
Checkmate Pharmaceuticals Announces CEO TransitionAlan Fuhrman, experienced biotech executive and Checkmate board member, appointed as interim President and CEO
Published: 2021-10-27 (Crawled : 23:00) - biospace.com/
CMPI | $10.5 0.0%
|
Health Technology
|
| O: -0.0%
H: 1.96%
C: -3.91%
biotech ceo iot leo
TYME Technologies, Inc. to Host Conference Call and Webcast on Monday, November 8th at 8:30 AM ET
Published: 2021-10-27 (Crawled : 23:00) - biospace.com/
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: 1.69%
H: 0.0%
C: -2.03%
conference
PPD Reports Third Quarter and Year-To-Date 2021 Results
Published: 2021-10-27 (Crawled : 23:00) - biospace.com/
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: 0.78%
H: 1.49%
C: -0.73%
CG | $46.13 -0.43% -0.43% 1.4M
|
Finance
|
| O: -0.34%
H: 0.21%
C: -1.75%
results
Innoviva Reports Third Quarter 2021 Financial Results
Published: 2021-10-27 (Crawled : 23:00) - biospace.com/
INVA | $15.15 -0.13% -0.13% 420K
|
Health Technology
|
| O: 0.25%
H: 1.19%
C: 0.94%
financial results results
CONMED Corporation Announces Third Quarter Financial Results
Published: 2021-10-27 (Crawled : 23:00) - biospace.com/
CNMD | $70.01 -1.82% -3.0% 1.2M
|
Health Technology
|
| O: -0.37%
H: 0.04%
C: -2.27%
CNMD | $70.01 -1.82% -3.0% 1.2M
|
Health Technology
|
| O: -0.37%
H: 0.04%
C: -2.27%
financial results results
Supernus to Announce Third Quarter 2021 Financial Results and Host Conference Call on November 3, 2021
Published: 2021-10-27 (Crawled : 23:00) - globenewswire.com
SUPN | $30.26 1.04% 1.02% 200K
|
Health Technology
|
| O: 2.5%
H: 0.48%
C: -1.91%
financial results results conference
Precigen to Host R&D Update Virtual Event on November 4th to Share Clinical Developments
Published: 2021-10-27 (Crawled : 21:00) - prnewswire.com
PGEN | $1.42 1.43% 1.41% 560K
|
Health Technology
|
| O: 0.22%
H: 10.2%
C: 9.98%
USD 2 Billion Growth expected in Clinical Staffing Services Market by 2024 | 1,200+ Sourcing and Procurement Report | SpendEdge
Published: 2021-10-27 (Crawled : 21:00) - prnewswire.com
ICLR | News | $308.79 0.76% 0.76% 960K
|
Health Technology
|
| O: 0.51%
H: 1.33%
C: 1.15%
growth
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for Phase 1/1b Clinical Trial of ITK Inhibitor CPI-818 in ChinaCPI-818 clinical trial in China will be conducted by Angel Pharmaceuticals
Published: 2021-10-27 (Crawled : 21:00) - biospace.com/
CRVS | $1.58 3.27% 3.16% 91K
|
Health Technology
|
| O: -2.45%
H: 5.25%
C: 4.11%
phase 1 china trial approval
Align Technology Announces Record Third Quarter 2021 Financial Results
Published: 2021-10-27 (Crawled : 21:00) - biospace.com/
ALGN | $313.95 0.66% 7.48% 1.1M
|
Health Technology
|
| O: -0.34%
H: 4.05%
C: 2.22%
financial results results technology
Volumetric to Be Acquired by 3D Systems to Advance Tissue and Organ Manufacturing
Published: 2021-10-27 (Crawled : 21:00) - biospace.com/
DDD 4 | $3.47 -0.86% 1.44% 1.1M
|
Producer Manufacturing
|
| O: -0.73%
H: 3.82%
C: -5.09%
UTHR | $237.06 1.11% 1.09% 610K
|
Health Technology
|
| O: -0.42%
H: 0.11%
C: -1.85%
acquired
Alnylam Reports Positive Topline 18-Month Results from HELIOS-A Phase 3 Study of Vutrisiran in Patients with hATTR Amyloidosis with Polyneuropathy
Published: 2021-10-27 (Crawled : 21:00) - biospace.com/
ALNY | $143.8 -1.55% -1.58% 390K
|
Health Technology
|
| O: -0.42%
H: 0.24%
C: -3.2%
positive results topline phase 3
Dyadic to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021
Published: 2021-10-27 (Crawled : 21:00) - globenewswire.com
DYAI 4 | $1.52 2.01% 1.97% 3.4K
|
Health Technology
|
| O: 0.71%
H: 2.82%
C: -0.24%
financial results results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.